| 1 | Erythema Nodosum | 45.8% |
| 2 | Serum Sickness | 45.8% |
| 3 | Toxic Epidermal Necrolysis | 36.7% |
| 4 | Stevens-Johnson Syndrome | 36.7% |
| 5 | Asthma, Aspirin-Induced | 21% |
| 6 | Dermatitis, Atopic | 19.8% |
| 7 | Contact Dermatitis | 19.6% |
| 8 | Eczema | 19.6% |
| 9 | Intertrigo | 19.6% |
| 10 | Neurodermatitis | 19.6% |
| 11 | Perioral Dermatitis | 19.6% |
| 12 | Dermatitis Herpetiformis | 19.3% |
| 13 | Acrodermatitis | 16.4% |
| 14 | Gianotti-Crosti Syndrome | 16.4% |
| 15 | Dermatitis, Allergic Contact | 15.7% |
| 16 | Pyoderma Gangrenosum | 14.8% |
| 17 | Dermatitis, Photoallergic | 13.8% |
| 18 | Lupus Erythematosus, Cutaneous | 13.4% |
| 19 | Panniculitis | 13.4% |
| 20 | Systemic Scleroderma | 13.4% |
| 21 | Morphea | 13.4% |
| 22 | Mastocytosis | 13.2% |
| 23 | Dermatitis, Irritant | 12.9% |
| 24 | Dermatitis, Phototoxic | 12.9% |
| 25 | Phototoxicity | 12.9% |
| 26 | Breast Diseases | 12.4% |
| 27 | Exanthema | 12.4% |
| 28 | Facial Dermatoses | 12.4% |
| 29 | Hair Diseases | 12.4% |
| 30 | Hand Dermatoses | 12.4% |
| 31 | Immune Complex Diseases | 12.4% |
| 32 | keratoacanthoma | 12.4% |
| 33 | Keratosis | 12.4% |
| 34 | Nail Diseases | 12.4% |
| 35 | Photosensitivity Disorders | 12.4% |
| 36 | Prurigo | 12.4% |
| 37 | Pyoderma | 12.4% |
| 38 | Rosacea | 12.4% |
| 39 | Sebaceous Gland Diseases | 12.4% |
| 40 | Skin Diseases, Vesiculobullous | 12.4% |
| 41 | Skin Ulcer | 12.4% |
| 42 | Sweat Gland Diseases | 12.4% |
| 43 | Anticholinergic Syndrome | 12.4% |
| 44 | Skin Diseases, Papulosquamous | 12.4% |
| 45 | Skin Diseases, Vascular | 12.4% |
| 46 | Acneiform Eruptions | 12.4% |
| 47 | Ocular Rosacea | 12.4% |
| 48 | Latex allergy | 12.4% |
| 49 | Subcorneal pustular dermatosis | 12.4% |
| 50 | Serotonin Syndrome | 12.4% |
| 51 | Propofol Infusion Syndrome | 12.4% |
| 52 | Erythematotelangiectatic Rosacea | 12.4% |
| 53 | Papulopustular Rosacea | 12.4% |
| 54 | Chronic Actinic Dermatitis | 12.4% |
| 55 | Acne Vulgaris | 11.8% |
| 56 | Erythema Multiforme | 11.8% |
| 57 | Rhinophyma | 11.8% |
| 58 | Urticaria | 11.8% |
| 59 | Acne | 11.8% |
| 60 | Chemical and Drug Induced Liver Injury | 11.3% |
| 61 | Dermatitis, Occupational | 11.2% |
| 62 | Epidermolysis Bullosa | 11.1% |
| 63 | Xeroderma Pigmentosum | 10.9% |
| 64 | Foot Diseases | 10.3% |
| 65 | Environmental Illness | 10.3% |
| 66 | Skin Abnormalities | 10.1% |
| 67 | Skin Diseases, Infectious | 10.1% |
| 68 | Skin Neoplasms | 10.1% |
| 69 | Pigmentation Disorders | 10.1% |
| 70 | Metabolic Side Effects of Drugs and Substances | 10.1% |
| 71 | Lipomatosis | 9.9% |
| 72 | Pruritus | 9.9% |
| 73 | Erythema | 9.9% |
| 74 | Injection Site Reaction | 9.9% |
| 75 | Necrolytic Migratory Erythema | 9.9% |
| 76 | Cutaneous Fistula | 9.9% |
| 77 | Infusion site reaction | 9.9% |
| 78 | Nephrogenic Fibrosing Dermopathy | 9.9% |
| 79 | Nephrogenic Systemic Fibrosis | 9.9% |
| 80 | Sebaceous Gland Neoplasms | 9.8% |
| 81 | Porokeratosis | 9.8% |
| 82 | Keratoderma, Palmoplantar | 9.8% |
| 83 | Foot Ulcer | 9.7% |
| 84 | Pityriasis Lichenoides et Varioliformis Acuta | 9.7% |
| 85 | Pityriasis Lichenoides | 9.7% |
| 86 | Diaper Rash | 9.6% |
| 87 | Dermatomyositis | 9.5% |
| 88 | Necrobiosis Lipoidica Diabeticorum | 9.3% |
| 89 | Panniculitis, Lupus Erythematosus | 9.3% |
| 90 | Pemphigus | 9.3% |
| 91 | Xeroderma | 8.5% |
| 92 | Kounis Syndrome | 8.3% |
| 93 | Erythema Induratum | 8.3% |
| 94 | Urticaria Pigmentosa | 8.1% |
| 95 | Argyria | 7.8% |
| 96 | Lupus Erythematosus, Discoid | 7.8% |
| 97 | Scleroderma, Limited | 7.8% |
| 98 | Acne Conglobata | 7.7% |
| 99 | Cutis Laxa | 7.7% |
| 100 | Autoimmune Diseases | 7.7% |
| 101 | Connective Tissue Diseases | 7.7% |
| 102 | Immunologic Deficiency Syndromes | 7.7% |
| 103 | Immunoproliferative Disorders | 7.7% |
| 104 | Poisoning | 7.7% |
| 105 | Immune reconstitution syndrome | 7.7% |
| 106 | Immune Reconstitution Inflammatory Syndrome | 7.7% |
| 107 | Pseudoxanthoma Elasticum | 7.6% |
| 108 | Akathisia, Drug-Induced | 7.5% |
| 109 | Ectodermal Dysplasia | 7.4% |
| 110 | Aplasia Cutis Congenita | 7.4% |
| 111 | anaphylaxis | 7.3% |
| 112 | Anhidrosis | 7.3% |
| 113 | Cholesteatoma | 7.3% |
| 114 | Pressure Ulcer | 7.3% |
| 115 | Folliculitis | 7.3% |
| 116 | Food Allergy | 7.3% |
| 117 | Foot Dermatoses | 7.3% |
| 118 | Gynecomastia | 7.3% |
| 119 | Hypertrichosis | 7.3% |
| 120 | Hypohidrosis | 7.3% |
| 121 | Hypotrichosis | 7.3% |
| 122 | Leg Ulcer | 7.3% |
| 123 | Miliaria | 7.3% |
| 124 | Parakeratosis | 7.3% |
| 125 | Parapsoriasis | 7.3% |
| 126 | Pityriasis | 7.3% |
| 127 | Psoriasis | 7.3% |
| 128 | Sweet Syndrome | 7.3% |
| 129 | Hidradenitis | 7.3% |
| 130 | Onycholysis | 7.3% |
| 131 | Miliaria Rubra | 7.3% |
| 132 | Hyperpigmentation | 7.3% |
| 133 | Lichenoid Eruptions | 7.3% |
| 134 | Chloracne | 7.3% |
| 135 | Anaphylactic shock | 7.3% |
| 136 | Cardiotoxicity | 7.2% |
| 137 | Erythema Infectiosum | 7.1% |
| 138 | Exanthema Subitum | 7% |
| 139 | Lupus Erythematosus, Systemic | 6.7% |
| 140 | Overlap syndrome | 6.7% |
| 141 | Dyskinesia, Drug-Induced | 6.6% |
| 142 | Angioedema | 6.6% |
| 143 | Chemical and Drug Induced Liver Injury, Chronic | 6.6% |
| 144 | Papillon-Lefevre Disease | 6.5% |
| 145 | Drug abuse | 6.4% |
| 146 | Substance Dependence | 6.4% |
| 147 | Substance-Related Disorders | 6.4% |
| 148 | Drug Dependence | 6.4% |
| 149 | Tinea Capitis | 6.2% |
| 150 | Onychomycosis | 6.2% |
| 151 | Transfusion Reaction | 6.2% |
| 152 | Hypotensive Transfusion Reaction | 6.2% |
| 153 | Respiratory Hypersensitivity | 6.1% |
| 154 | Ecthyma | 6.1% |
| 155 | Granuloma Annulare | 6% |
| 156 | Acantholysis | 6% |
| 157 | Breast Cyst | 6% |
| 158 | Actinic keratosis | 6% |
| 159 | Pemphigoid, Benign Mucous Membrane | 6% |
| 160 | Piedra | 6% |
| 161 | Sick Building Syndrome | 6% |
| 162 | Sunburn | 6% |
| 163 | Multiple Chemical Sensitivity | 6% |
| 164 | Hirsutism | 5.9% |
| 165 | Lactation Disorder | 5.9% |
| 166 | Mastitis | 5.9% |
| 167 | Vasculitis, Leukocytoclastic, Cutaneous | 5.9% |
| 168 | Adiposis Dolorosa | 5.8% |
| 169 | Pruritus Vulvae | 5.8% |
| 170 | Mastocytoma | 5.8% |
| 171 | Pruritus Ani | 5.8% |
| 172 | Ichthyosis, X-Linked | 5.7% |
| 173 | Sjogren-Larsson Syndrome | 5.7% |
| 174 | Behcet Syndrome | 5.5% |
| 175 | Hyperkeratosis, Epidermolytic | 5.3% |
| 176 | Glomerulonephritis, Membranoproliferative | 5% |
| 177 | Dermatomycoses | 5% |
| 178 | Mucocutaneous Lymph Node Syndrome | 5% |
| 179 | Skin Diseases, Bacterial | 5% |
| 180 | Albinism | 4.9% |
| 181 | Lipodystrophy | 4.9% |
| 182 | Livedo Reticularis | 4.9% |
| 183 | Malignant Atrophic Papulosis | 4.9% |
| 184 | Hidradenitis Suppurativa | 4.9% |
| 185 | Polyarteritis Nodosa | 4.9% |
| 186 | Takayasu Arteritis | 4.9% |
| 187 | Erythema Chronicum Migrans | 4.8% |
| 188 | Lichen Planus | 4.8% |
| 189 | Melanosis | 4.8% |
| 190 | Chloasma | 4.8% |
| 191 | Pityriasis Rosea | 4.8% |
| 192 | Pityriasis Rubra Pilaris | 4.8% |
| 193 | Vitiligo | 4.8% |
| 194 | Milk Allergy | 4.8% |
| 195 | Lichen Nitidus | 4.8% |
| 196 | Wheat Hypersensitivity | 4.8% |
| 197 | Psychoses, Substance-Induced | 4.8% |
| 198 | Nail-Patella Syndrome | 4.3% |
| 199 | Porphyrias, Hepatic | 4.3% |
| 200 | Tinea Pedis | 4.2% |
| 201 | Angioedemas, Hereditary | 4.2% |
| 202 | Collagen Diseases | 4.1% |
| 203 | Fluoride Poisoning | 4.1% |
| 204 | Food Poisoning | 4.1% |
| 205 | Gas Poisoning | 4.1% |
| 206 | Mixed Connective Tissue Disease | 4.1% |
| 207 | Mycotoxicosis | 4.1% |
| 208 | Plant Poisoning | 4.1% |
| 209 | Antiphospholipid Syndrome | 4.1% |
| 210 | Mucinoses | 4.1% |
| 211 | Organophosphate poisoning | 4.1% |
| 212 | Hereditary Angioedema Type III | 4% |
| 213 | Hereditary Angioedema Types I and II | 4% |
| 214 | Alopecia | 3.9% |
| 215 | Sweating, Gustatory | 3.9% |
| 216 | Androgenetic Alopecia | 3.9% |
| 217 | Auriculotemporal Syndrome | 3.9% |
| 218 | Mushroom Poisoning | 3.9% |
| 219 | Lice Infestations | 3.9% |
| 220 | Varicose Ulcer | 3.9% |
| 221 | Breast Neoplasms, Male | 3.9% |
| 222 | Triple Negative Breast Neoplasms | 3.9% |
| 223 | Mycetoma | 3.9% |
| 224 | Galactorrhea | 3.9% |
| 225 | Mastocytosis, Systemic | 3.9% |
| 226 | Rheumatoid Arthritis | 3.8% |
| 227 | Autoimmune Lymphoproliferative Syndrome | 3.8% |
| 228 | Juvenile arthritis | 3.8% |
| 229 | Thrombocytopenic purpura | 3.7% |
| 230 | Acanthosis Nigricans | 3.6% |
| 231 | Alopecia Areata | 3.6% |
| 232 | Lentigo | 3.6% |
| 233 | Giant Cell Arteritis | 3.6% |
| 234 | Temporal Arteritis | 3.6% |
| 235 | Bites and Stings | 3.4% |
| 236 | Cartilage Diseases | 3.4% |
| 237 | Rheumatism | 3.4% |
| 238 | Chondromalacia | 3.4% |
| 239 | Neurotoxicity Syndromes | 3.4% |
| 240 | Lymphoproliferative Disorders | 3.4% |
| 241 | Marijuana Abuse | 3.4% |
| 242 | Opioid-Related Disorders | 3.4% |
| 243 | Nicotine Dependence | 3.4% |
| 244 | Opioid abuse | 3.4% |
| 245 | Phencyclidine Abuse | 3.4% |
| 246 | Substance Abuse, Intravenous | 3.4% |
| 247 | Substance Withdrawal Syndrome | 3.4% |
| 248 | Tobacco Use Disorder | 3.4% |
| 249 | Alcohol-Related Disorders | 3.4% |
| 250 | Amphetamine-Related Disorders | 3.4% |
| 251 | Cocaine-Related Disorders | 3.4% |
| 252 | Addison Disease | 3.3% |
| 253 | Paraproteinemias | 3.3% |
| 254 | Water Intoxication | 3.3% |
| 255 | Arsenic Poisoning | 3.3% |
| 256 | Autoimmune thyroiditis | 3.3% |
| 257 | Primary Adrenal Insufficiency | 3.3% |
| 258 | Larva Migrans | 3.3% |
| 259 | Leishmaniasis | 3.3% |
| 260 | Molluscum Contagiosum | 3.3% |
| 261 | Lymphopenia | 3.3% |
| 262 | Drug Overdose | 3.3% |
| 263 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3.3% |
| 264 | Autoimmune hepatitis | 3.3% |
| 265 | Autoimmune thrombocytopenia | 3.3% |
| 266 | Immune thrombocytopenic purpura | 3.3% |
| 267 | Onchocerciasis | 3.3% |
| 268 | Chromoblastomycosis | 3.2% |
| 269 | Dermatophytosis | 3.2% |
| 270 | Sporotrichosis | 3.2% |
| 271 | Tinea | 3.2% |
| 272 | Tinea Versicolor | 3.2% |
| 273 | Trichophytosis | 3.2% |
| 274 | Hyalohyphomycosis | 3.2% |
| 275 | HIV-Associated Lipodystrophy Syndrome | 3.2% |
| 276 | Lichen Planus, Oral | 3% |
| 277 | CREST Syndrome | 2.9% |
| 278 | Asthma | 2.9% |
| 279 | Warts | 2.9% |
| 280 | Neonatal Abstinence Syndrome | 2.8% |
| 281 | Primary amyloidosis | 2.8% |
| 282 | Hypergammaglobulinemia | 2.8% |
| 283 | Candidiasis, Chronic Mucocutaneous | 2.8% |
| 284 | Cutaneous Candidiasis | 2.8% |
| 285 | Monoclonal Gammopathy of Undetermined Significance | 2.8% |
| 286 | Erysipelas | 2.8% |
| 287 | Staphylococcal Skin Infections | 2.8% |
| 288 | Variegate Porphyria | 2.8% |
| 289 | Acute intermittent porphyria | 2.8% |
| 290 | Porphyria Cutanea Tarda | 2.8% |
| 291 | Latent Autoimmune Diabetes in Adults | 2.8% |
| 292 | Lupus Nephritis | 2.8% |
| 293 | Erythrasma | 2.8% |
| 294 | Carcinoma, Lobular | 2.8% |
| 295 | Agammaglobulinemia | 2.8% |
| 296 | Arthritis, Psoriatic | 2.8% |
| 297 | HIV Infections | 2.7% |
| 298 | Alcohol-Induced Disorders, Nervous System | 2.7% |
| 299 | Transfusion-Related Acute Lung Injury | 2.7% |
| 300 | Dupuytren Contracture | 2.7% |
| 301 | Aspergillosis, Allergic Bronchopulmonary | 2.5% |
| 302 | Asthma, Exercise-Induced | 2.4% |
| 303 | Cadmium poisoning | 2.4% |
| 304 | Carbon Monoxide Poisoning | 2.4% |
| 305 | Ciguatera Poisoning | 2.4% |
| 306 | Ergotism | 2.4% |
| 307 | Lead Poisoning | 2.4% |
| 308 | Mercury Poisoning | 2.4% |
| 309 | Status Asthmaticus | 2.4% |
| 310 | Alcohol-Induced Disorders | 2.4% |
| 311 | Scleromyxedema | 2.4% |
| 312 | Shellfish Poisoning | 2.4% |
| 313 | Leishmaniasis, Cutaneous | 2.4% |
| 314 | Eczema Herpeticum | 2.4% |
| 315 | Fusariosis | 2.4% |
| 316 | Graves Disease | 2.4% |
| 317 | Alcohol Withdrawal Delirium | 2.4% |
| 318 | Cellulitis | 2.4% |
| 319 | Alcohol Withdrawal Seizures | 2.4% |
| 320 | Anti-Glomerular Basement Membrane Disease | 2.3% |
| 321 | Felty Syndrome | 2.3% |
| 322 | Psychoses, Alcoholic | 2.3% |
| 323 | Menkes Kinky Hair Syndrome | 2.2% |
| 324 | Blastomycosis | 2.2% |
| 325 | Multiple Myeloma | 2.2% |
| 326 | Asthma, Occupational | 2.2% |
| 327 | Farmer's Lung | 2.1% |
| 328 | Epidermodysplasia Verruciformis | 2.1% |
| 329 | Herpes Labialis | 2.1% |
| 330 | Hay fever | 2.1% |
| 331 | Rhinitis, Allergic, Perennial | 2.1% |
| 332 | Diabetic Foot | 2.1% |
| 333 | Staphylococcal Scalded Skin Syndrome | 2.1% |
| 334 | Rheumatoid Vasculitis | 2% |
| 335 | Rhinoscleroma | 2% |
| 336 | Insect Bites and Stings | 2% |
| 337 | Mesenteric Panniculitis | 2% |
| 338 | Panniculitis, Peritoneal | 2% |
| 339 | Tietze's Syndrome | 2% |
| 340 | Orbital Cellulitis | 2% |
| 341 | Myxoid cyst | 2% |
| 342 | Alcohol Use Disorder | 2% |
| 343 | Alcoholic Intoxication | 2% |
| 344 | Heroin Dependence | 2% |
| 345 | Morphine Dependence | 2% |
| 346 | Myxedema | 2% |
| 347 | Plasmacytoma | 2% |
| 348 | Tumor Lysis Syndrome | 2% |
| 349 | Alcohol abuse | 2% |
| 350 | Manganese Poisoning | 2% |
| 351 | HTLV-I Infections | 1.9% |
| 352 | Job Syndrome | 1.9% |
| 353 | Salmonella food poisoning | 1.9% |
| 354 | Lupus Vasculitis, Central Nervous System | 1.8% |
| 355 | Kernicterus | 1.8% |
| 356 | Condylomata Acuminata | 1.8% |
| 357 | Noonan Syndrome | 1.8% |
| 358 | Furunculosis | 1.8% |
| 359 | furuncle | 1.8% |
| 360 | Sicca Syndrome | 1.8% |
| 361 | Sjogren's Syndrome | 1.8% |
| 362 | Impetigo | 1.8% |
| 363 | Peutz-Jeghers Syndrome | 1.8% |
| 364 | carbuncle | 1.7% |
| 365 | Osteochondritis | 1.7% |
| 366 | Polymyalgia Rheumatica | 1.7% |
| 367 | Marfan Syndrome | 1.7% |
| 368 | Ataxia Telangiectasia | 1.7% |
| 369 | Sezary Syndrome | 1.7% |
| 370 | Lymphoma | 1.7% |
| 371 | Myasthenia Gravis | 1.7% |
| 372 | Uveomeningoencephalitic Syndrome | 1.7% |
| 373 | Neuroleptic Malignant Syndrome | 1.6% |
| 374 | Osteogenesis Imperfecta | 1.6% |
| 375 | Hydrops Fetalis | 1.6% |
| 376 | Chronic granulomatous disease | 1.6% |
| 377 | Heavy Chain Disease | 1.6% |
| 378 | Binge Drinking | 1.6% |
| 379 | Granulomatosis with polyangiitis | 1.6% |
| 380 | Keloid | 1.6% |
| 381 | Homocystinuria | 1.6% |
| 382 | HIV Seropositivity | 1.6% |
| 383 | Schnitzler Syndrome | 1.6% |
| 384 | Myasthenia Gravis, Autoimmune, Experimental | 1.4% |
| 385 | Stiff-Person Syndrome | 1.4% |
| 386 | Polyradiculoneuropathy | 1.4% |
| 387 | Polyradiculoneuritis | 1.4% |
| 388 | Botulism | 1.4% |
| 389 | Acquired Immunodeficiency Syndrome | 1.4% |
| 390 | AIDS related complex | 1.4% |
| 391 | Infectious Mononucleosis | 1.4% |
| 392 | MPTP Poisoning | 1.4% |
| 393 | Cryoglobulinemia | 1.4% |
| 394 | POEMS Syndrome | 1.4% |
| 395 | Cardiomyopathy, Alcoholic | 1.3% |
| 396 | Pancreatitis, Alcoholic | 1.3% |
| 397 | Mercury Poisoning, Nervous System | 1.3% |
| 398 | Lead Poisoning, Nervous System | 1.3% |
| 399 | Laryngomalacia | 1.3% |
| 400 | Pectus carinatum | 1.3% |
| 401 | AIDS-Related Opportunistic Infections | 1.2% |
| 402 | Vasculitis, Central Nervous System | 1.2% |
| 403 | HIV Wasting Syndrome | 1.2% |
| 404 | Wernicke Encephalopathy | 1.2% |
| 405 | AIDS Dementia Complex | 1.2% |
| 406 | AIDS-Associated Nephropathy | 1.2% |
| 407 | Tick Paralysis | 1.2% |
| 408 | Lambert-Eaton Myasthenic Syndrome | 1.1% |
| 409 | Fetal Alcohol Spectrum Disorders | 1.1% |
| 410 | Waldenstrom Macroglobulinemia | 1.1% |
| 411 | Wiskott-Aldrich Syndrome | 1.1% |
| 412 | Multiple Sclerosis | 1.1% |
| 413 | Hodgkin Disease | 1.1% |
| 414 | Leukemia, Plasma Cell | 1.1% |
| 415 | Lymphoma, Non-Hodgkin | 1.1% |
| 416 | Rheumatoid Nodule | 1.1% |
| 417 | Leukemia, T-Cell | 1.1% |
| 418 | Leukemia, B-Cell | 1.1% |
| 419 | Neuromyelitis Optica | 1% |
| 420 | Leukoencephalitis, Acute Hemorrhagic | 1% |
| 421 | Lead Poisoning, Nervous System, Childhood | 1% |
| 422 | Lead Poisoning, Nervous System, Adult | 1% |
| 423 | Bronchomalacia | 0.9% |
| 424 | Composite Lymphoma | 0.9% |
| 425 | Tracheomalacia | 0.9% |
| 426 | Encephalomyelitis, Acute Disseminated | 0.9% |
| 427 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.9% |
| 428 | Neuritis, Autoimmune, Experimental | 0.9% |
| 429 | Lymphangioleiomyomatosis | 0.9% |
| 430 | Guillain-Barre Syndrome | 0.8% |
| 431 | Fatty Liver, Alcoholic | 0.8% |
| 432 | Hepatitis, Alcoholic | 0.8% |
| 433 | Liver Cirrhosis, Alcoholic | 0.8% |
| 434 | Acrodynia | 0.8% |
| 435 | Multiple Sclerosis, Chronic Progressive | 0.8% |
| 436 | Multiple Sclerosis, Relapsing-Remitting | 0.8% |
| 437 | Lymphoma, Follicular | 0.8% |
| 438 | T-Cell Lymphoma | 0.8% |
| 439 | Mantle cell lymphoma | 0.8% |
| 440 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 441 | Mucopolysaccharidosis III | 0.8% |
| 442 | Leukemia, Large Granular Lymphocytic | 0.8% |
| 443 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 444 | Lymphoma, T-Cell, Cutaneous | 0.7% |
| 445 | Lymphoma, AIDS-Related | 0.7% |
| 446 | Enteropathy-Associated T-Cell Lymphoma | 0.7% |
| 447 | Primary Effusion Lymphoma | 0.7% |
| 448 | Mycosis Fungoides | 0.6% |
| 449 | Lymphomatoid Papulosis | 0.6% |
| 450 | Plasmablastic lymphoma | 0.6% |
| 451 | Myelitis, Transverse | 0.6% |
| 452 | Mucopolysaccharidosis II | 0.6% |
| 453 | Lymphomatoid Granulomatosis | 0.6% |
| 454 | Burkitt Lymphoma | 0.5% |
| 455 | Miller Fisher Syndrome | 0.4% |